Michael K Handley
CIK 1451334 · Chief Executive Officer · last filed 2026-05-20
Michael K Handley is a Chief Executive Officer who has filed 7 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for VBIO, was dated May 20, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
7
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VBIO | Chief Executive Officer | 11,030 | — | — | $0 | 1 | 2026-05-20 |
| Valion Bio, Inc. (TIVC) Delisted | Chief Operating Officer | 8,824 | $1.40 | $12.4K | $0 | 4 | 2026-02-20 |
| Statera Biopharma, Inc. (CBLI) Delisted | President and CEO | 296,609 | $3.17 | $940.3K | $0 | 1 | 2021-08-04 |
| SPECTRANETICS CORP (SPNC) Delisted | VP Global Reg. Affairs & Comp | — | — | — | $0 | 1 | 2008-12-10 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | VBIO | Exer (M) | +2,206 | $0 | EDGAR |
| 2026-02-20 | Valion Bio, Inc. (TIVC) Delisted | Exer (M) | +8,824 | $0 | EDGAR |
| 2025-08-22 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-08-08 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-02-24 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-04 | Statera Biopharma, Inc. (CBLI) Delisted | Grant (A) | +296,609 | $0 | EDGAR |
| 2008-12-10 | SPECTRANETICS CORP (SPNC) Delisted | Grant (A) | — | $0 | EDGAR |